AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18785581
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (IT) group
Trial: 18785581
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy (RT) group
Trial: 16415711
Drug: Mirtazapine orally
RxNorm normalized name: Mirtazapine Orally Disintegrating Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine orally disintegrating tablets (ODT) 45 mg OD
Trial: 16415711
Drug: Venlafaxine extended-release
RxNorm normalized name: Desvenlafaxine Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine extended-release (XR) 225 mg OD
Trial: 8867517
Drug: Diethylpropion 25
RxNorm normalized name: diethylpropion 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylpropion 25 mg
Trial: 8867517
Drug: Diethylpropion 50
RxNorm normalized name: diethylpropion 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylpropion 50 mg
Trial: 8867517
Drug: Diethylpropion 75
RxNorm normalized name: diethylpropion 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylpropion 75 mg
Trial: 22533981
Drug: ONO‐5334 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐5334 30 mg
Trial: 22533981
Drug: ONO‐5334 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐5334 100 mg
Trial: 22533981
Drug: ONO‐5334 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐5334 300 mg
Trial: 22533981
Drug: ONO‐5334 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐5334 600 mg
Trial: 11873074
Drug: High-titered ALVAC-HIV
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-titered ALVAC-HIV vCP205 vaccine
Trial: 6633272
Drug: Org OD
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org OD 14 (2.5 mg daily for 4 months)
Trial: 6633272
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 tablet daily for 4 months)
Trial: 6633272
Drug: Org OD
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org OD 14 and lynestrenol (1 mg daily during days 91-100)
Trial: 6633272
Drug: Withdrawal bleeding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal bleeding after cessation of treatment
Trial: 31033162
Drug: Robust skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robust skin care regimen including chemical peels and antioxidant formulations (Group B)
Trial: 30028657
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate 1,000 mg daily and prednisone 5 mg twice daily with enzalutamide
Trial: 27265347
Drug: S-1 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 (40 mg, 50 mg, or 60 mg according to body-surface area, orally administered twice a day for 28 days followed by a 14 day rest, every 6 weeks for up to four cycles)
Trial: 27265347
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m2, intravenously administered on days 1, 8, and 15, every 4 weeks for up to six cycles)
Trial: 20354539
Drug: Stereotactic radiosurgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic radiosurgery (SRS) with whole-brain radiation therapy (WBRT)
Trial: 18228689
Drug: New treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New treatments for orphan diseases
Trial: 12468561
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg ascorbic acid daily by mouth
Trial: 9709941
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral magnesium (15 mmol Mg) supplementation
Trial: 2122926
Drug: Propranolol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (mean daily dose, 293 mg)
Trial: 2122926
Drug: Diltiazem (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (mean daily dose, 350 mg)
Trial: 2122926
Drug: Nifedipine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (mean daily dose, 79 mg)
Trial: 21816845
Drug: 200-mg-bid celecoxib
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200-mg-bid celecoxib
Trial: 21816845
Drug: 400-mg-bid celecoxib
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400-mg-bid celecoxib
Trial: 18093337
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy (CBT) plus pill placebo
Trial: 15075550
Drug: AIDSVAX B/E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIDSVAX B/E HIV vaccine trial
Trial: 11594256
Drug: Incision or
RxNorm normalized name: INCISED NOTOPTERYGIUM RHIZOME OR ROOT (NOTOPTERYGIUM FRANCHETII)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incision or aspiration with antibiotics
Trial: 2974776
Drug: Sorbinil (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorbinil (250 mg daily)
Trial: 25636180
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (1,200 mg/day of eicosapentaenoic acid and 600 mg/day of docosahexaenoic acid for 90 days)
Trial: 23201326
Drug: Tibolone (2.5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone (2.5mg daily)
Trial: 20568387
Drug: Subcutaneous immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunotherapy (SCIT) injections
Trial: 18586644
Drug: Fish sauce
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish sauce containing 10 mg of iron (either as NaFe‐EDTA or FeSO4+citrate)
Trial: 12668405
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CBT) and supportive psychotherapy (SPT) combined
Trial: 1526089
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg nizatidine twice daily
Trial: 1526089
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg nizatidine at bedtime
Trial: 29750261
Drug: Sequential intensity-modulated
RxNorm normalized name: California intense cedar pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential intensity-modulated radiation therapy
Trial: 24906029
Drug: Tolvaptan (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (15 mg/day, titrated to 30 mg/day and 60 mg/day)
Trial: 22502793
Drug: Intra-articular hyaluronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular hyaluronic acid (HA) injections plus physical therapy (PT)
Trial: 18614875
Drug: Low serum
RxNorm normalized name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Sunceutical SPF 50 Mineral Glow Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low serum alpha-fetoprotein level (<5.0 ng/ml)
Trial: 7719750
Drug: Lavender oil
RxNorm normalized name: Lavender oil
DrugBank: Lavender oil (DB14566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lavender oil (6 drops added to bath water daily for 10 days)
Trial: 2189075
Drug: Enalapril, 10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril, 10-20 mg
Trial: 2189075
Drug: Captopril, 50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril, 50-100 mg
Trial: 27324141
Drug: Flatbreads with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flatbreads with 6 g GG, 4 g KM, and 15 g CPF plus 2 or 4 g GG
Trial: 26206423
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (843.0 +/- 44.0 mg/day epigallocatechin gallate)
Trial: 23590801
Drug: Corticosteroids (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (with immunosuppressant adjunct when corticosteroids failed)
Trial: 23590801
Drug: Anti-myeloperoxidase antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-myeloperoxidase antibodies
Trial: 19121573
Drug: guaifenesin 600
RxNorm normalized name: guaifenesin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: guaifenesin 600 mg (G)
Trial: 19121573
Drug: benzonatate 200
RxNorm normalized name: benzonatate 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benzonatate 200 mg (B)
Trial: 19121573
Drug: combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combination of benzonatate 200 mg and guaifenesin 600 mg (B+G)
Trial: 9540874
Drug: Natural somatostatin
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural somatostatin (single bolus injection)
Trial: 8126502
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg levodopa/50 mg carbidopa with 200 mg entacapone
Trial: 8126502
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg levodopa/50 mg carbidopa with 800 mg entacapone
Trial: 1092513
Drug: Deanol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deanol (500 mg daily)
Trial: 1092513
Drug: Methylphenidate (40
RxNorm normalized name: methylphenidate (40/60 release) 15 mg/24 hr oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (40 mg daily)
Trial: 27652589
Drug: Prasugrel 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 20 mg single dose
Trial: 27652589
Drug: Prasugrel 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 30 mg single dose
Trial: 27652589
Drug: Prasugrel 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 20 mg loading dose followed by 5 mg/day maintenance dose
Trial: 27652589
Drug: Prasugrel 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 30 mg loading dose followed by 7.5 mg/day maintenance dose
Trial: 21615670
Drug: Exenatide 10
RxNorm normalized name: EXENATIDE 10MCG/DOSE 2.4ML 60D PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide 10 µg (subcutaneous) twice daily
Trial: 21615670
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg (oral) daily
Trial: 7907097
Drug: ipsapirone (10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone (10.0 to 30.0 mg daily)
Trial: 7907097
Drug: lorazepam (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam (2.0 to 6.0 mg daily)
Trial: 28478185
Drug: Bupivacaine liposome
RxNorm normalized name: bupivacaine liposome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine liposome injectable suspension (80cc plus 1.3% liposomal bupivacaine 20cc; total injection 100cc)
Trial: 28478185
Drug: Ropivacaine (periarticular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (periarticular injection of ropivacaine, ketorolac, morphine, and epinephrine in saline; 100cc)
Trial: 21696635
Drug: EPA‐rich fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA‐rich fish oil supplement (1060 mg EPA plus 274 mg DHA)
Trial: 21696635
Drug: DHA‐rich fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA‐rich fish oil supplement (900 mg DHA plus 180 mg EPA)
Trial: 1675650
Drug: 4% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% chlorhexidine detergent solution (Group A)
Trial: 7093110
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg aspirin
Trial: 30552505
Drug: 6.4 g
RxNorm normalized name: BENZOCAINE 6.4 g in 32 g ORAL GEL [Mark 3]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.4 g day−1 of sustained-release beta-alanine (CarnoSyn™, NAI, USA)
Trial: 31089253
Drug: Sesame oil
RxNorm normalized name: Sesame Oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sesame oil enriched with vitamin E (30 ml/day and 400 mg/day)
Trial: 31089253
Drug: Sesame oil
RxNorm normalized name: Sesame Oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sesame oil (30 ml/day)
Trial: 31089253
Drug: Sunflower oil
RxNorm normalized name: Sunflower Oil
DrugBank: Sunflower oil (DB14329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunflower oil (30 ml/day)
Trial: 27865620
Drug: Chokeberry juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chokeberry juice (300 mL/d)
Trial: 24518194
Drug: Home-based exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based exercise training in combination with conventional management (EX, n = 20)
Trial: 22206079
Drug: Tri-retinol 1.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tri-retinol 1.1% cream
Trial: 20565456
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg i.v. administration of CAT-354
Trial: 20565456
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg s.c. administration of CAT-354
Trial: 20565456
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg s.c. administration of CAT-354 (two 150 mg injections)
Trial: 9279180
Drug: Nebulised frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised frusemide (1 mg/kg/body weight)
Trial: 9279180
Drug: Intravenous frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous frusemide (1 mg/kg/body weight)
Trial: 2423806
Drug: Indoramin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoramin (50 mg t.i.d. per os)
Trial: 23073712
Drug: Daily home-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily home-based exercise programme and self-care (n=11)
Trial: 18204344
Drug: Current treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current treatment (Control)
Trial: 16600940
Drug: Yogurt-plus-quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yogurt-plus-quadruple therapy (AB-yogurt 400 mL/d for 4 weeks + quadruple therapy for 1 week)
Trial: 16600940
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy only (without AB-yogurt)
Trial: 14967868
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g CHO as a glucose solution at 15 min before exercise (‐15 trial)
Trial: 14967868
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g CHO as a glucose solution at 75 min before exercise (‐75 trial)
Trial: 14967868
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g CHO as a glucose solution 45 min before exercise
Trial: 14967868
Drug: 200 g
RxNorm normalized name: PEG-200 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 g CHO as a glucose solution 45 min before exercise
Trial: 8770990
Drug: 15 mg/day
RxNorm normalized name: Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/day dose of anti-LFA1 monoclonal antibody (MoAb) with a loading dose of 30 mg
Trial: 8770990
Drug: Additional group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional group receiving the same protocol (15 mg/day with a loading dose of 30 mg)
Trial: 1282180
Drug: Nicorandil 20
RxNorm normalized name: nicorandil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 20 mg b.i.d. for 4 weeks
Trial: 1282180
Drug: Isosorbide-5-mononitrate (MN)
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (MN) 20 mg b.i.d. for 4 weeks
Trial: 1282180
Drug: Nicorandil 10
RxNorm normalized name: nicorandil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 10 mg t.i.d. for 2 weeks then 20 mg t.i.d. for 4 weeks
Trial: 1282180
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) 10 mg t.i.d. for 2 weeks then 20 mg t.i.d. for 4 weeks
Trial: 16487032
Drug: IFN in
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN in combination with amantadine or ribavirin
Trial: 14761489
Drug: Blood transfusion
RxNorm normalized name: Blood transfusion, auxiliary products
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusion and scopolamine injection in addition to traditional therapy (gastrolavage, purgation, redox agent)
Trial: 14761489
Drug: Traditional combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional combined therapy (gastrolavage, purgation, redox agent)
Trial: 8970901
Drug: Fractional excretion
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional excretion of free Dpyr
Trial: 6697676
Drug: Cefazolin 20
RxNorm normalized name: cefazolin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 20 mg/kg i.v. administered with anesthesia
Trial: 6697676
Drug: Cefazolin 20
RxNorm normalized name: cefazolin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 20 mg/kg i.v. administered 'on call'
Trial: 6697676
Drug: Cefoxitin 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin 30 mg/kg i.v. administered with anesthesia
Trial: 6697676
Drug: Cefoxitin 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin 30 mg/kg i.v. administered 'on call'
Trial: 29102648
Drug: Both radiation
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both radiation and systemic therapy
Trial: 29102648
Drug: Systemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic therapy with radiation
Trial: 24559003
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei shirota (LcS) at a dose of 16 x 10(9) CFU
Trial: 24559003
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei shirota (LcS) at a dose of 8 x 10(9) CFU
Trial: 22118417
Drug: Dexeryl (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexeryl (an emollient cream containing glycerol 15% and paraffin 10%)
Trial: 20616762
Drug: 6-dose group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-dose group (reduced 5-component acellular pertussis vaccine combined with tetanus toxoid and reduced diphtheria toxoid)
Trial: 20616762
Drug: 5-dose group
RxNorm normalized name: meningococcal group B vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-dose group (Tdap vaccine)
Trial: 9915320
Drug: 0.025 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 mg/kg etomidate
Trial: 9915320
Drug: 0.050 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.050 mg/kg etomidate
Trial: 9915320
Drug: 0.075 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075 mg/kg etomidate
Trial: 9915320
Drug: 0.100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.100 mg/kg etomidate
Trial: 9915320
Drug: 0.200 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.200 mg/kg etomidate
Trial: 9915320
Drug: 0.300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.300 mg/kg etomidate
Trial: 9915320
Drug: 0.050 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.050 mg/kg etomidate (pretreatment)
Trial: 9915320
Drug: 0.030 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.030 mg/kg etomidate (pretreatment)
Trial: 9915320
Drug: 0.075 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075 mg/kg etomidate (pretreatment)
Trial: 7751875
Drug: Single-agent bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent bolus 5-FU
Trial: 7751875
Drug: Unmodulated infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unmodulated infusion regimens
Trial: 7751875
Drug: 5-FU bolus
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU bolus therapy
Trial: 2261951
Drug: Low-dose ara-C
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ara-C in combination with 13-cis-retinoic acid (13-CRA) and 1 alpha-hydroxy-vitamin D3 (1 alpha D3)
Trial: 2261951
Drug: Low-dose ara-C
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ara-C (arm A)
Trial: 26041848
Drug: FX006 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FX006 (10 mg)
Trial: 26041848
Drug: FX006 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FX006 (40 mg)
Trial: 26041848
Drug: FX006 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FX006 (60 mg)
Trial: 26041848
Drug: Immediate-release triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate-release triamcinolone acetonide (40 mg)